Literature DB >> 16928172

Treatment of acute pulmonary embolism: local effects of three hydrodynamic thrombectomy devices in an ex vivo porcine model.

Jürgen Biederer1, Nikolas Charalambous, Friedrich Paulsen, Martin Heller, Stefan Müller-Hülsbeck.   

Abstract

PURPOSE: To report an ex vivo study on the local effects of hydrodynamic thrombectomy for the treatment of acute pulmonary embolism (off-label use).
METHODS: Three devices (6-F AngioJet Xpeedior and 6-F and 8-F Oasis) were used for hydrodynamic thrombectomy inside the arteries of 24 inflated and perfused porcine lung explants. Each system was used at multiple positions inside 4 intact and 4 embolized lungs in vessels measuring 2 to 4 mm, 4 to 6 mm, 6 to 8 mm, and 8 to 10 mm. Angiograms prior to, during, and after catheter positioning and system operation were used to detect arterial wall trauma and to measure local clot removal per 30-second cycle. A total of 21 vessel wall samples were subjected to scanning electron microscopy (SEM) to evaluate non-perforating lesions.
RESULTS: All systems were able to remove clot material. The average recanalized vessel length normalized to 30 seconds for vessel diameters of 2 to 4 and 8 to 10 mm, respectively, was 1.17 and 1.75 cm (AngioJet), 0.97 and 0.25 cm (6-F Oasis), and 2.2 and 1.05 cm (8-F Oasis). Perforations occurred during positioning of the 6-F Oasis (4/78 maneuvers) and 8-F Oasis (13/60), but not the AngioJet (0/89); perforations were also seen during system operation (AngioJet: 21/89 activations, 6-F Oasis: 4/78, and 8-F Oasis: 9/60; all lesions inside vessels <6 mm in diameter). SEM showed 35 lesions, 14 with perforation (contrast extravasation) and 21 without perforation (induced by the tip of the guidewire).
CONCLUSION: The AngioJet was most efficient in clot removal, followed by the 8-F Oasis. The 6-F Oasis was least efficient, but had fewest complications. According to these experiments, the tested hydrodynamic thrombectomy devices may cause perforations in vessels <6 mm in diameter. Changes in catheter design to reduce system-specific complication rates or to improve the efficacy of clot removal are warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16928172     DOI: 10.1583/06-1862.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  3 in total

1.  Experimental model of large pulmonary embolism employing controlled release of subacute caval thrombus in swine.

Authors:  Israel M Barbash; William H Schenke; Majdi Halabi; Kanishka Ratnayaka; Anthony Z Faranesh; Ozgur Kocaturk; Robert J Lederman
Journal:  J Vasc Interv Radiol       Date:  2011-07-28       Impact factor: 3.464

2.  The first experience of catheter based pulmonary embolectomy in iran: a new horizon in therapy of massive pulmonary emboli.

Authors:  J Kojuri; P Dehghani; M A Ostovan; A R Abdi; M J Zibaeenejad
Journal:  Iran Red Crescent Med J       Date:  2011-11-01       Impact factor: 0.611

3.  A porcine in-vivo model of acute pulmonary embolism.

Authors:  Jacob Schultz; Asger Andersen; Inger Lise Gade; Steffen Ringgaard; Benedict Kjaergaard; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2017-10-03       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.